| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 08/09/2011 | CA2177043C Hepatoblasts and method of isolating same |
| 08/04/2011 | WO2011094579A2 Mushroom compositions and methods for making and using |
| 08/04/2011 | WO2011094489A1 Therapies for treating hepatitis c virus infection |
| 08/04/2011 | WO2011093441A1 Therapeutic or prophylactic agent for biliary diseases |
| 08/04/2011 | WO2011093308A1 Prophylactic or therapeutic agent for crohn's disease comprising organic acid polymer as active ingredient |
| 08/04/2011 | WO2011092835A1 Antiseptic solution for continuous oral disinfection |
| 08/04/2011 | WO2011092537A1 Composition and method for treating ulcers |
| 08/04/2011 | WO2011092290A1 Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists |
| 08/04/2011 | WO2011092261A1 Probiotic composition for use in the treatment of bowel inflammation |
| 08/04/2011 | WO2011091757A1 Polyheterocyclic compounds highly potent as hcv inhibitors |
| 08/04/2011 | WO2011091461A1 Compounds for use in the treatment of diseases |
| 08/04/2011 | WO2011019210A9 Dietary supplement, feed and pharmaceutical composition containing chia seed and maca, and preparation method thereof |
| 08/04/2011 | WO2011001400A9 Processes for the preparation of form i and form ii of palonosetron hydrochloride |
| 08/04/2011 | US20110190399 Curcumin nanoparticles and methods of producing the same |
| 08/04/2011 | US20110190395 Novel sulphur containing lipids for use as food supplement or as medicament |
| 08/04/2011 | US20110190360 Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists |
| 08/04/2011 | US20110190342 Glycine b antagonist |
| 08/04/2011 | US20110190339 6-substituted isoquinolines and isoquinolinones |
| 08/04/2011 | US20110190319 Substituted heteroaryl fused derivatives as pi3k inhibitors |
| 08/04/2011 | US20110190317 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 08/04/2011 | US20110190308 Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
| 08/04/2011 | US20110190303 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 08/04/2011 | US20110190298 4-phenoxymethylpiperidines as modulators of gpr119 activity |
| 08/04/2011 | US20110190263 Compounds and compositions as modulators of gpr119 activity |
| 08/04/2011 | US20110190260 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 08/04/2011 | US20110190256 Amine and Ether Compounds Which Modulate The CB2 Receptor |
| 08/04/2011 | US20110190240 Nuclear factor kappa b pathway inhibitor composition and use of same |
| 08/04/2011 | US20110190225 Topical method for prompt relief of severe ascites |
| 08/04/2011 | US20110190214 Advantageous Salts of Mu-Opiate Receptor Peptides |
| 08/04/2011 | US20110189285 Hydrogel capable of containing and conveying cells |
| 08/04/2011 | US20110189271 Pharmaceutical formulations of acid-labile drugs |
| 08/04/2011 | US20110189220 Mushroom compositions and methods for making and using |
| 08/04/2011 | US20110189212 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
| 08/04/2011 | US20110189189 Combination of cd137 antibody and ctla-4 antibody for the treatment of proliferative diseases |
| 08/04/2011 | US20110189188 Novel gp96 derived peptides |
| 08/04/2011 | US20110189177 Antibodies to vla-1 |
| 08/04/2011 | US20110189148 Lactose compositions with decreased lactose content |
| 08/04/2011 | US20110189147 Process and composition for the manufacture of a microbial-based product |
| 08/04/2011 | US20110189146 Methods of Use of Probiotic Lactobacilli for Companion Animals |
| 08/04/2011 | US20110189145 Inhibition of Pathogens by Probiotic Bacteria |
| 08/04/2011 | US20110189139 Hematopoietic Cell E-Selectin/L-Selectin Ligand Glycosylated CD44 Polypeptide |
| 08/04/2011 | US20110189131 Active variants of the il-18 binding protein and medical uses thereof |
| 08/04/2011 | US20110189129 Hepatitis c virus inhibitors |
| 08/04/2011 | US20110189128 Recombinant super-compound interferon |
| 08/04/2011 | US20110189091 Colon lavage system |
| 08/04/2011 | US20110189082 Human gm-csf antigen binding proteins |
| 08/04/2011 | DE102010044870A1 Hemmung des Überlebens von Mundhöhlenkrebs durch Cyclohexenonverbindungen aus Antrodia camphorata Inhibition of survival of oral cancer by cyclohexenone from Antrodia camphorata |
| 08/04/2011 | CA2788348A1 Therapies for treating hepatitis c virus infection |
| 08/04/2011 | CA2788326A1 Compounds for use in the treatment of diseases |
| 08/04/2011 | CA2788155A1 Polyheterocyclic compounds highly potent as hcv inhibitors |
| 08/04/2011 | CA2787544A1 Probiotic composition for use in the treatment of bowel inflammation |
| 08/04/2011 | CA2787323A1 Therapeutic or prophylactic agent for biliary tract diseases |
| 08/04/2011 | CA2783518A1 Bottled ozonated water system |
| 08/04/2011 | CA2783420A1 Prophylactic or therapeutic agent for crohn's disease comprising organic acid polymer as active ingredient |
| 08/04/2011 | CA2752473A1 Composition and method for treating ulcers |
| 08/03/2011 | EP2351836A1 Double-stranded oligonucleotides |
| 08/03/2011 | EP2351832A1 Composition for inducing th2 cell, therapeutic composition for th2-type disease, and use of same |
| 08/03/2011 | EP2351765A2 Oligonucleotide-containing pharmacological compositions and their use |
| 08/03/2011 | EP2351754A1 Phenanthroindolizidine compound and nf b inhibitor containing same as active ingredient |
| 08/03/2011 | EP2351753A1 Phenanthroindolizidine derivative and nf b inhibitor containing same as active ingredient |
| 08/03/2011 | EP2351748A1 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
| 08/03/2011 | EP2351585A1 Anti-hepatitis c virus composition |
| 08/03/2011 | EP2351572A1 Agent having anti-helicobacter pylori activity |
| 08/03/2011 | EP2351563A1 Agent for treatment of diabetes |
| 08/03/2011 | EP2351561A2 Novel methods and compositions for alleviating pain |
| 08/03/2011 | EP2351558A1 Therapeutic agent for tympanites in ruminant animal |
| 08/03/2011 | EP2351492A1 Nutritional composition with probiotics |
| 08/03/2011 | EP2350266A1 Method for treating or preventing a pancreatic dysfunction |
| 08/03/2011 | EP2350096A1 Methods of treating hepatic encephalopathy |
| 08/03/2011 | EP2350050A1 Process for the preparation of enantiomerically enriched proton pump inhibitors |
| 08/03/2011 | EP2349277A2 Methods of identification of novel ligands for modulation of orphan nuclear receptor rar-related orphan receptor-gamma (nr1f3) activity |
| 08/03/2011 | EP2349250A1 Fatty acids for use as a medicament |
| 08/03/2011 | EP2349236A2 Compositions and methods for treating or preventing hypoxic or ischemic injury |
| 08/03/2011 | EP2114970B1 Tricyclic compounds and their use as glucocorticoid receptor modulators |
| 08/03/2011 | EP1534753B1 Peg positional isomer of an anti-tnfalpha antibody (cdp870) |
| 08/03/2011 | CN201912293U 脐疝袋 Umbilical hernia bag |
| 08/03/2011 | CN1931239B Chinese medicine prepn for treating hepatitis B |
| 08/03/2011 | CN1898240B Imidazopyrazine tyrosine kinase inhibitors |
| 08/03/2011 | CN1700934B Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 08/03/2011 | CN102143940A Cyclohexyl amide derivatives and their use as CRF-1 receptor antagonists |
| 08/03/2011 | CN102143751A Use of rifalazil to treat colonic disorders |
| 08/03/2011 | CN102143745A Oxazolidinones for the treatment of inflammatory conditions of the gastrointestinal tract |
| 08/03/2011 | CN102140460A SiRNA (Small interference ribonucleic acid) as well as medicine composition and pharmaceutical application thereof |
| 08/03/2011 | CN102140458A SiRNA (Small interference ribonucleic acid) as well as medicine composition and pharmaceutical application thereof |
| 08/03/2011 | CN102140385A Novel process for extracting amomum fruit leaf oil |
| 08/03/2011 | CN102140100A Polycyclic compound for inhibiting hepatitis C virus efficiently, preparation method thereof and application thereof |
| 08/03/2011 | CN102140099A Novel pyridine derivative |
| 08/03/2011 | CN102140092A Hydrate of ilaprazole salt, preparation method thereof and application thereof |
| 08/03/2011 | CN102140064A Compounds for the treatment of metabolic disorders |
| 08/03/2011 | CN102139108A Co-ground materials of benzimidazoles proton pump inhibitors and hydrophilic polymer auxiliary materials |
| 08/03/2011 | CN102139084A Chinese medicinal composition for treating fatty liver and preparation method and application thereof |
| 08/03/2011 | CN102139083A Formula of medicament for treating cholecystitis and urolithiasis |
| 08/03/2011 | CN102139082A Liver soothing potion |
| 08/03/2011 | CN102139081A Chinese medicinal composition and preparation for treating recurrent oral ulcer and preparation method thereof |
| 08/03/2011 | CN102139080A Chinese medicinal composition for treating chronic gastritis and peptic ulcer and preparation method thereof |
| 08/03/2011 | CN102139070A Prescription for treating stomach diseases |
| 08/03/2011 | CN102139066A Chinese medicinalal soft capsule |
| 08/03/2011 | CN102139061A Traditional Chinese medicine for treating diabetic constipation |
| 08/03/2011 | CN102139058A Traditional Chinese medicine for treating stomach diseases |
| 08/03/2011 | CN102139055A Traditional Chinese medicine for treating diabetic gastroplegia |